Goldman Sachs Maintains Neutral on Definitive Healthcare, Lowers Price Target to $3
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Goldman Sachs analyst Kash Rangan maintains Definitive Healthcare (NASDAQ:DH) with a Neutral and lowers the price target from $4.5 to $3.
Goldman Sachs analyst Kash Rangan maintains Definitive Healthcare (NASDAQ:DH) with a Neutral and lowers the price target from $4.5 to $3.